RxDoctor Payments Data

Stephen Litman

Internal Medicine · Dresher, PANPI 1033115134

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,812 of the $3,711 with a category attached, or 75.8%. Eli Lilly accounts for 63.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $2,346 and has fallen 55.8% since, to $1,037 in 2025.

$3,711in general payments, 2019–2025

Across 43 payments — averaging $86.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Merck$1K
  • AbbVie$47
  • Astellas Pharma US Inc$36
  • Amarin Pharma, Inc.$30
  • Lilly USA, LLC$29
  • plus $137 from 6 others
$2,030,268in research payments, 2019–2025

Across 23 payments — averaging $88,273 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2M
  • Genentech, Inc.$10K

What the payments were for

  • Travel & lodging$2,81276%
  • Food & beverage$89924%

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,711 in reported general payments places this provider in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania

Other internal medicine in Dresher

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →